s6y
Night mode
Documents
Document List
REXAHN PHARMACEUTICALS, INC 10-K 12-31-2013
EXHIBIT 3.2
EXHIBIT 23.1
EXHIBIT 24.1
EXHIBIT 31.1
EXHIBIT 31.2
EXHIBIT 32.1
EXHIBIT 32.2
Summary of Significant Accounting Policies (Concentrations of Credit Risk) (Details) (USD $)
Dec. 31, 2013
Summary of Significant Accounting Policies [Abstract]
Cash, Uninsured Amount
$ 17,972,641